Star Health and Allied Insurance Company Limited (STARHEALTH.BO)
INR 484.25
(-0.6%)
INR 484.25
(-0.6%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.68 Billion | 12.01 Billion | 290.42 Million | 8.64 Billion | 6.21 Billion | 7.59 Billion |
| Net Income | 8.45 Billion | 6.18 Billion | -10.4 Billion | -8.25 Billion | 2.63 Billion | 1.28 Billion |
| Depreciation & Amortization | 587.07 Million | 520.67 Million | 432.98 Million | 457.3 Million | 294.4 Million | 280.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 4.23 Billion | 5.3 Billion | 10.26 Billion | 16.44 Billion | 3.29 Billion | 6.03 Billion |
| Investing Cash Flow | -11.76 Billion | -10.97 Billion | -37.86 Billion | -24.18 Billion | -10.05 Billion | -7.31 Billion |
| Investments in PPE | -1.23 Billion | -465.9 Million | -631.3 Million | -460.85 Million | -337.24 Million | -385.45 Million |
| Acquisitions | 9 Million | 818 Thousand | 3.05 Million | 150 Thousand | 1.37 Million | 78.13 Million |
| Investment purchases | -1785.4 Billion | -1313.92 Billion | -1566.27 Billion | -348.67 Billion | -75.86 Billion | -30.35 Billion |
| Sales/Maturities of investments | 1765.09 Billion | 1295.76 Billion | 1522.4 Billion | 321.26 Billion | 63.53 Billion | 21.54 Billion |
| Other Investing Activities | 9.77 Billion | 7.65 Billion | 6.64 Billion | 3.69 Billion | 2.6 Billion | 1.79 Billion |
| Financing Cash Flow | 229.8 Million | -2.68 Billion | 25.09 Billion | 26.13 Billion | 1.21 Billion | 3.33 Billion |
| Debt repayment | - | -2.5 Billion | -4.7 Billion | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -44.47 Million | -292.35 Million | - | - | - |
| Common Stock Issuance | 641 Million | 608 Million | 20.94 Billion | 26.44 Billion | 1.47 Billion | 3.5 Billion |
| Other Financing Activities | -411.2 Million | -743.52 Million | 9.4 Billion | -311.47 Million | -256 Million | -165.58 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 2.88 Billion | 3.77 Billion | 15.99 Billion | 5.13 Billion | 7.5 Billion | 3.71 Billion |
| Cash at end of period | 4.44 Billion | 2.88 Billion | 3.77 Billion | 15.99 Billion | 5.13 Billion | 7.5 Billion |
| Capital Expenditure | -1.23 Billion | -465.9 Million | -631.3 Million | -460.85 Million | -337.24 Million | -385.45 Million |
| Effect of forex changes on cash | - | 743.5 Million | 265.27 Million | 255.99 Million | 255.99 Million | 165.58 Million |
| Net cash flow / Change in cash | 1.56 Billion | -893.3 Million | -12.21 Billion | 10.85 Billion | -2.36 Billion | 3.78 Billion |
| Free Cash Flow | 11.45 Billion | 11.54 Billion | -340.87 Million | 8.18 Billion | 5.88 Billion | 7.21 Billion |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.45 Billion | 2.89 Billion | 1.25 Billion | 2.87 Billion | 6.18 Billion | 1.01 Billion |
| Depreciation & Amortization | 587.07 Million | - | - | - | 520.67 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 4.23 Billion | -2.89 Billion | -1.25 Billion | -2.87 Billion | 5.3 Billion | -1.01 Billion |
| Investing Cash Flow | -11.76 Billion | - | - | - | -10.97 Billion | - |
| Investments in PPE | -1.23 Billion | - | - | - | -465.9 Million | - |
| Acquisitions | 9 Million | - | - | - | 818 Thousand | - |
| Investment purchases | -1785.4 Billion | - | - | - | -1313.92 Billion | - |
| Sales/Maturities of investments | 1765.09 Billion | - | - | - | 1295.76 Billion | - |
| Other Investing Activities | 9.77 Billion | - | - | - | 7.65 Billion | - |
| Financing Cash Flow | 229.8 Million | - | - | - | -2.68 Billion | - |
| Debt repayment | - | - | - | - | -2.5 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -44.47 Million | - |
| Common Stock Issuance | 641 Million | - | - | - | 608 Million | - |
| Other Financing Activities | - | - | - | - | -743.52 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 2.88 Billion | 2.66 Billion | 1.41 Billion | 2.88 Billion | 3.77 Billion | 1.86 Billion |
| Cash at end of period | 4.44 Billion | 2.89 Billion | 2.66 Billion | 2.87 Billion | 2.88 Billion | 2.88 Billion |
| Capital Expenditure | -1.23 Billion | - | - | - | -465.9 Million | - |
| Effect of forex changes on cash | - | - | - | - | 743.5 Million | - |
| Net cash flow / Change in cash | 1.56 Billion | 226 Million | 1.25 Billion | -5.06 Million | -893.3 Million | 1.01 Billion |
| Free Cash Flow | 11.45 Billion | 2.89 Billion | 1.25 Billion | 2.87 Billion | 11.54 Billion | 1.01 Billion |
VRNS
STARCEMENT
1982
BIOSK
VTS
1082